助听器对耳聋患者的耳鸣治疗效果的观察40例

目的 分析研究助听器对耳聋患者的耳鸣治疗效果。方法 选取本院2018年6月-2019年6月期间收治的40例耳聋伴耳鸣患者进行此次研究,对佩戴助听器前、佩戴助听器3个月和佩戴助听器6个月的患者使用耳鸣残疾量表(THI)进行检测,并且对患者佩戴前后的评分状况进行对比。结果 患者佩戴助听器三个月和六个月的THI评分对比没有显著的差异,不具有统计学意义(P>0.05);但是佩戴助听器前进行对比,其评分低于佩戴前并且差异极为显著,具有统计学意义(P<0.05);佩戴助听器12个月的患者其治疗成效明显优于佩戴助听器3个月的患者,具有统计学意义(P<0.05)。结论 助听器可以对耳聋患者的耳鸣状况进行进一步的改善,并且佩戴时间越长其治疗成效也就越明显,在临床中有着推广价值。

The NGF Point-Injection for Treatment of the Sound-Perceiving Nerve Deafness and Tinnitus in 68 Cases

Objective: To observe the therapeutic effects of the point-injection with nerve growth factor (NGF) for the sound-perceiving nerve deafness and tinnitus. Methods: The 140 cases in this series were randomly divided into a treatment group of 68 cases treated by NGF injection at the points of Yifeng (TE 17) and Wangu (GB 12), and a control group of 72 cases orally taking Xibiling (西比灵) and adenosine triphosphate (ATP) and intramuscular injection with VB1 and VB12. Results: The total effective rate was 78.6% in the treatment group and 31.8% in the control group, with significant difference between the two groups (P<0.05). Conclusion: For treating nervous deafness and tinnitus, NGF point-injection may show good therapeutic effects, but inversely proportional to the illness course, age and the extent of hypoacusis.